// App-Quantinova.ai

2808 : Oxidative status of mouse azoxymethane (AOM)/dextran sulfate sodium (DSS)-induced colitis-associated cancer model and the effects of COX-2 inhibitor

Researchers

Presenter

  • Gorkem Kismali

Principal Investigators

  • Aykut Gokturk Uner

  • Ogunc Meral

  • Merve Alpay

  • Dilek Ulker Cakir

  • Funda Kosova

  • Tevhide Sel

Medical Centers

  • Ankara University, Ankara, Turkey

  • Harvard University, Boston, MA

  • Duzce University, Duzce, Turkey

  • Canakkale Onsekiz Mart University, Canakkale, Turkey.

  • Celal Bayar University, Manisa, Turkey

Locations

  • United States

  • Turkey

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gastrointestinal bleeding

  • Colitic cancer

  • Ulcerative colitis

  • Solid malignancies

Biomarkers

  • Nucleoside diphosphate kinase A

  • Cyclooxygenase-2

  • Malondialdehyde

  • Superoxide dismutase

  • Advanced oxidation protein products

Drug/Treatment

  • dextran sulfate sodium

  • Superoxide dismutase

  • Dextran sulfate

  • Azoxymethane

  • Meloxicam

  • Dex-HEMA

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved